Adjuvant and salvage radiation therapy after prostatectomy: American Society for Radiation Oncology/American Urological Association guidelines.
about
Gaps between Evidence and Practice in Postoperative Radiotherapy for Prostate Cancer: Focus on Toxicities and the Effects on Health-Related Quality of LifeRationale and development of image-guided intensity-modulated radiotherapy post-prostatectomy: the present standard of care?Radiation therapy after radical prostatectomy for prostate cancer: evaluation of complications and influence of radiation timing on outcomes in a large, population-based cohort.Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapyEvaluating the clinical impact of a genomic classifier in prostate cancer using individualized decision analysis.Long-term tolerance and outcomes for dose escalation in early salvage post-prostatectomy radiation therapy.Current status and outcomes of patients developing PSA recurrence after prostatectomy who were treated with salvage radiotherapy: a JROSG surveillance study.High-risk prostate cancer-classification and therapy.Radiation treatment in older patients: a framework for clinical decision making.Progress and controversies: Radiation therapy for prostate cancer.Intermediate-term outcome after PSMA-PET guided high-dose radiotherapy of recurrent high-risk prostate cancer patients.Magnetic resonance imaging for prostate cancer before radical and salvage radiotherapy: What radiation oncologists need to know.Adjuvant versus salvage radiotherapy in prostate cancer: multi-institutional retrospective analysis of the Spanish RECAP database.Toxicity after post-prostatectomy image-guided intensity-modulated radiotherapy using Australian guidelines.Impact of 68Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy.Early salvage radiation therapy post-prostatectomy: key considerations.Radiotherapy after prostatectomy: prognosis, timing and outcomes.Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography.Adjuvant Versus Early Salvage Radiation Therapy Following Radical Prostatectomy for Men with Localized Prostate Cancer.Target volume definition for post prostatectomy radiotherapy: Do the consensus guidelines correctly define the inferior border of the CTV?Management of prostate cancer patients following radiation therapy after radical surgery referred from urology to radiation oncology departments in Spain.[Begin salvage radiotherapy early after diagnosis of PSA recurrence].A population-based analysis of contemporary patterns of care in younger men (<60 years old) with localized prostate cancer.Salvage radiation therapy following radical prostatectomy. A national Danish study.Providing guidance for genomics-based cancer treatment decisions: insights from stakeholder engagement for post-prostatectomy radiation therapy.Positive surgical margins in radical prostatectomy patients do not predict long-term oncological outcomes: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) cohort.Continuous prostate-specific antigen rise despite salvage radiotherapy following radical prostatectomy: Pattern of clinical relapse and predictive factors.Radiation therapy after radical prostatectomy: A single-centre radiation oncology experience in trends of referral and treatment practices.Delineation of the Prostate Bed: The "Invisible Target" Is Still an Issue?Postoperative radiotherapy in prostate cancer: Analysis of prognostic factors in a series of 282 patients.Outcomes of post-prostatectomy radiotherapy at a Regional Cancer Centre.Detection of Local Recurrence with 3-Tesla MRI After Radical Prostatectomy: A Useful Method for Radiation Treatment Planning?Functional and oncological outcomes of salvage external beam radiotherapy following robot-assisted radical prostatectomy in a Canadian cohort.Postoperative radiotherapy for prostate cancer : Morbidity of local-only or local-plus-pelvic radiotherapy.Interobserver variation in target volume for salvage radiotherapy in recurrent prostate cancer patients after radical prostatectomy using CT versus combined CT and MRI: a multicenter study (KROG 13-11).High postprostatectomy prostate-specific antigen level prior to salvage radiation therapy is not always a bad sign.Prospective MRI-based imaging study to assess feasibility of proton therapy for post-prostatectomy radiation.Splenic Irradiation for the Treatment of Severe Antibody-Mediated Rejection.Application of a hydrogel spacer for postoperative salvage radiotherapy of prostate cancer.
P2860
Q26751574-FFC58525-64C0-4C02-88A4-E0E6AFFBB789Q26774847-2EBD13C9-F1A5-4FDE-B008-BDEBC993D021Q30300626-FC9882EE-2BF1-4D3C-8100-FB668F9DD3E4Q30371634-59CDCE76-0E6A-4ABF-AE7E-56637DF17ECEQ30405851-5B26093B-3CFC-413C-A31D-8FE7F8981F18Q34325482-9FCB7A02-4922-405A-8A9F-083376E99602Q35835157-FBE2AD55-7160-42D1-B872-62CC3CEB1334Q35869811-E0F77565-33AA-4AE0-926B-8595F8F311DAQ36925147-CE0D3041-B19B-4BF2-942E-DDB0725B4F82Q38252429-A69DE079-5D65-47BA-BFAC-EAC07777C8EBQ38613594-7F24FA11-27AB-4D4F-BF54-8FBFE1007769Q38636446-0A5D2E5C-305E-4EC1-A388-1A2A889C6FC3Q38699141-D287A176-AC7D-4DE2-8951-17FCD541BDCAQ38721392-80A58613-B93D-456A-A12E-4990680B3410Q38804450-2D04685B-6756-4183-8D2C-129D4DA507ABQ38844315-996C2C1A-FDE4-44C6-A9B7-A654F1AD13A2Q38979418-197C0583-5D82-4417-9137-8518FB07B9E7Q38986405-4990C6B8-2227-41E6-8207-3657DEB00097Q38996907-7C0ED075-F209-401D-989F-C4A9EB5A28ADQ39356227-FEA9F404-6069-42A6-848D-4918C7255D5BQ39363908-E63D605E-B07B-4E98-807E-764AF3AA5C0DQ40258902-5C1073B0-119B-40CC-861C-7DF533695011Q40512483-3CDDB4B7-8469-48CF-B36D-D331F7247BA5Q40584866-35DACA63-B2D0-4703-8455-32303B5D4AF9Q41328641-0D4E8994-689C-4D23-939B-77292D23FF00Q41520709-1320C164-36B1-40B5-ACE1-014A7DFC7F01Q41718014-A2373289-A10F-433C-AB97-60981480F48FQ41822113-77680F63-3E61-471E-B846-FB0913E3067DQ41825752-565E2377-F687-4F37-96A9-D9D02E7F9D85Q42236979-55311796-73E6-4330-989D-B98137970BC7Q43154723-DE39B91F-68A4-4DD1-8BB6-6B7EC8674186Q47105326-8B507F31-B50D-4FBB-8E14-E875C9164CCBQ47253086-9EA9EA0B-8C28-4673-BBAE-D14A52BC68CCQ48510316-9B21C24D-85B6-48A7-93FA-91D813815D62Q50002077-D5499FAB-FDB8-4AD4-96AA-C8386D1B2933Q50062202-2E9C8EA5-8CD4-44CC-BE32-4339898A59B2Q50184921-84EE0E42-B492-4194-8985-79DB1DA83FE3Q52983195-DD976920-A836-45B6-8430-C406B40855B3Q53096184-57376486-9AC7-4861-BA1E-79B139B752CDQ53406446-20A8BD37-35A5-4D87-998B-E1E2B66C07C9
P2860
Adjuvant and salvage radiation therapy after prostatectomy: American Society for Radiation Oncology/American Urological Association guidelines.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Adjuvant and salvage radiation ...... ogical Association guidelines.
@en
type
label
Adjuvant and salvage radiation ...... ogical Association guidelines.
@en
prefLabel
Adjuvant and salvage radiation ...... ogical Association guidelines.
@en
P2093
P50
P1476
Adjuvant and salvage radiation ...... ogical Association guidelines.
@en
P2093
American Society for Radiation Oncology/American Urological Association
Carol Hahn
Eric Klein
Ian Thompson
J Stuart Wolf
Jeff Michalski
Martha M Faraday
Oliver Sartor
Peter Albertsen
Richard K Valicenti
P304
P356
10.1016/J.IJROBP.2013.05.029
P407
P577
2013-08-01T00:00:00Z